Success Story: NAILG Achieves NIW Approval for an Indian Clinical Associate Advancing Data-Verified Treatment Strategies
On February 13th, 2026, we received EB-2 NIW (National Interest Waiver) approval for a Clinical Associate in the Field of Internal Medicine (Approval Notice).
General Field: Internal Medicine
Position at the Time of Case Filing: Clinical Associate
Country of Origin: India
State of Residence at the Time of Filing: Ohio
Approval Notice Date: February 13th, 2026
Processing Time: 1 month, 25 days (Premium Processing Requested)
Case Summary:
Data-driven medicine is changing how clinicians choose the right treatment at the right time. In this NIW case, a researcher in Internal Medicine demonstrated that rigorous clinical research grounded in real-world data can strengthen care decisions and support U.S. efforts to confront persistent public health burdens. The petitioner, a physician from India holding an M.B.B.S., received approval in just under 2 months under Premium Processing, with North America Immigration Law Group (Chen Immigration Law Associates) guiding the petition to a successful outcome.
Addressing the National Burden of Cardiovascular Disease
The petitioner’s proposed endeavor focuses on advancing effect-driven research in internal medicine, with a specific focus on cardiovascular disease. By generating data-verified evidence to optimize treatment selection, his work aims to:
- Enhance Patient Outcomes: Tailoring therapeutic strategies and optimizing treatment selection based on individual patient characteristics.
- Reduce Mortality Rates: Targeting heart disease, which remains the leading cause of death in the United States, accounting for one in every five deaths.
- Mitigate Economic Impact: Alleviating the staggering burden placed on the U.S. economy by chronic illnesses like heart disease and stroke, which cost hundreds of billions in medical expenses and lost productivity annually.
Quantitative Record of Professional Achievement
To meet the high standards of the Dhanasar framework, we documented a substantial record of success that well-positioned the petitioner to advance his endeavor. At the time of filing, his professional portfolio included:
- Prolific Scholarly Authorship: 18 peer-reviewed journal articles, 23 abstracts, and 2 preprints.
- Widespread Scientific Influence: His work had garnered 130 citations, with several papers ranking in the top 0.1%, 1%, and 10% of most-cited articles for their respective publication years.
- Judicial Recognition: He has been entrusted by the scientific community to complete at least 3 peer reviews for authoritative journals.
Strategic Impact on U.S. Public Health
A key element of this successful petition was highlighting the "major significance" of the client's original contributions. As noted by a fellow expert from a leading U.S. medical institution:
"As an esteemed internal medicine expert, [Client] has elucidated the safety of key cardiovascular medications."
By demonstrating that the petitioner’s research aligns with federal health priorities, including those reflected in the U.S. Department of Health and Human Services’ Global Health Strategy, NAILG reinforced the national importance of the work and the value of the petitioner’s continued contributions in the United States. This approval allows an expert to remain at the forefront of clinical innovation.